BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10733530)

  • 41. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning and characterization of human DP2, a novel dimerization partner of E2F.
    Zhang Y; Chellappan SP
    Oncogene; 1995 Jun; 10(11):2085-93. PubMed ID: 7784053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of adenoviral proteins with pRB and p53.
    Moran E
    FASEB J; 1993 Jul; 7(10):880-5. PubMed ID: 8344487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
    Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATM is a target for positive regulation by E2F-1.
    Berkovich E; Ginsberg D
    Oncogene; 2003 Jan; 22(2):161-7. PubMed ID: 12527885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
    Alevizopoulos K; Sanchez B; Amati B
    Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of DNA synthesis and apoptosis are separable functions of E2F-1.
    Phillips AC; Bates S; Ryan KM; Helin K; Vousden KH
    Genes Dev; 1997 Jul; 11(14):1853-63. PubMed ID: 9242492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis.
    Kowalik TF; DeGregori J; Schwarz JK; Nevins JR
    J Virol; 1995 Apr; 69(4):2491-500. PubMed ID: 7884898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physical and functional interactions of neuronal growth suppressor necdin with p53.
    Taniura H; Matsumoto K; Yoshikawa K
    J Biol Chem; 1999 Jun; 274(23):16242-8. PubMed ID: 10347180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
    Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
    Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis.
    Gomez-Manzano C; Fueyo J; Alameda F; Kyritsis AP; Yung WK
    Int J Mol Med; 1999 Jan; 3(1):81-5. PubMed ID: 9864390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene.
    Hale TK; Braithwaite AW
    J Biol Chem; 1999 Aug; 274(34):23777-86. PubMed ID: 10446138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
    Komori H; Goto Y; Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
    Sci Rep; 2018 May; 8(1):8438. PubMed ID: 29855511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perp-etrating p53-dependent apoptosis.
    Ihrie RA; Attardi LD
    Cell Cycle; 2004 Mar; 3(3):267-9. PubMed ID: 14726658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
    Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
    Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perp is required for tissue-specific cell survival during zebrafish development.
    Nowak M; Köster C; Hammerschmidt M
    Cell Death Differ; 2005 Jan; 12(1):52-64. PubMed ID: 15529176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of a new member of the gas3/PMP22 gene family in C. elegans.
    Agostoni E; Gobessi S; Brancolini C; Schneider C
    Gene; 1999 Jul; 234(2):267-74. PubMed ID: 10395899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.